2020 ASCO Virtual Direct™ Highlights

 

Head&Neck
10:06

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on HPV+ Oropharynx Cancer: Can TORS and Reduced Dose Post-Operative RT Maintain High Cure Rates and Decrease Late Toxicity in Intermediate Risk Disease?

FEATURING Deborah Wong
  • 11 views
  • September 29, 2020
13:56

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates for High-Risk SCCHN: Is Post-Operative Weekly Cisplatin 40mg/m2 Inferior to Bolus Cisplatin With RT?

FEATURING Deborah Wong
  • 33 views
  • September 29, 2020
17:05

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Solid H&N Tumors With HRAS Mutations: Is Tipifarnib a Good Option for Post-Chemo Patients With SCCHN? Does Axitinib Improve Overall Outcomes?

FEATURING Deborah Wong
  • 20 views
  • September 29, 2020